AstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...

Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...

While recruitment and regulation are improving, they remain pain points, say speakers at Arena International’s OCT West Coast ...

X4 has entered an exclusive agreement with taiba rare for distributing and commercialising Xolremdi in select Middle Eastern ...

In this review, GlobalData considers the products both approved and priced in 2024 and the factors that influenced their ...

The World Health Organization (WHO) said it will conduct another mass vaccination round in the Gaza Strip to protect children ...

ImmunityBio has gained the FDA authorisation for an EAP to supply an alternative source of BCG for treating bladder cancer.

The FDA, NIH and CDC has cut 5,200 probationary staff in a job cull across the HHS over the Valentine's Day weekend.

FDA has granted priority review for Boehringer Ingelheim’s zongertinib NDA for treating unresectable or metastatic NSCLC.

A team of scientists has developed a new AI-based foundation model that can give insights into disease-causing mutations and ...

The company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...

Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.